Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
14,399
-1,824
-11% -$211K 0.01% 801
2026
Q1
$1.97M Buy
16,223
+13,509
+498% +$1.77M 0.01% 729
2025
Q4
$370K Sell
2,714
-41
-1% -$5.9K ﹤0.01% 1233
2025
Q3
$406K Buy
2,755
+688
+33% +$95.4K ﹤0.01% 1148
2025
Q2
$267K Sell
2,067
-43
-2% -$5.21K ﹤0.01% 1235
2025
Q1
$252K Buy
2,110
+176
+9% +$21.8K ﹤0.01% 1169
2024
Q4
$224K Buy
1,934
+17
+0.9% +$2.15K ﹤0.01% 1162
2024
Q3
$259K Buy
1,917
+1
+0.1% +$134 ﹤0.01% 1091
2024
Q2
$260K Buy
+1,916
New +$261K ﹤0.01% 1039
2023
Q1
Sell
-2,066
Closed -$228K 1009
2022
Q4
$228K Buy
+2,066
New +$217K ﹤0.01% 816

Other funds holding XYL

Equitable Holdings's XYL Position: Q2 2026 in Review

Equitable Holdings reduced its Xylem (XYL) stake by 11% in Q2 2026, selling an estimated $211K and leaving 14,399 shares worth $1.7M. The position accounts for 0.01% of the portfolio, ranked #801.

Equitable Holdings first reported a position in XYL in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.97M in Q1 2026. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Equitable Holdings held 14,399 shares of Xylem worth $1.7M as of Q2 2026.
  • Equitable Holdings sold 1,824 Xylem shares in Q2 2026, an estimated $211K.
  • Xylem made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #801 holding.
  • Equitable Holdings first reported a position in Xylem in Q4 2022 and has held it in 10 quarters since.
  • Equitable Holdings's Xylem position peaked at $1.97M in Q1 2026.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.